Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration

IMPORTANCE: Current studies assessing the risk of stroke, myocardial infarction (MI), and death in patients undergoing intravitreal anti–vascular endothelial growth factor (VEGF) therapy are inconclusive. To our knowledge, no population-based studies have been performed to examine these potential ri...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Ophthalmol
Autors principals: Dalvin, Lauren A., Starr, Matthew R., AbouChehade, Jackson E., Damento, Gena M., Garcia, Maria, Shah, Saumya M., Hodge, David O., Meissner, Irene, Bakri, Sophie J., Iezzi, Raymond
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512306/
https://ncbi.nlm.nih.gov/pubmed/30703203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaophthalmol.2018.6891
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars